Individual Investors Among Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Largest Stockholders and Were Hit After Last Week's 4.8% Price Drop

Simply Wall StDec 10, 2024 18:12 ET

Yizhong Pharmaceutical Gets Nod For Pancreatic Cancer Drug Trial

MT NewswiresOct 16, 2024 02:09 ET

Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) 26% Price Boost Is Out Of Tune With Earnings

Simply Wall StSep 27, 2024 18:52 ET

We Think Shanghai Yizhong Pharmaceutical (SHSE:688091) Can Stay On Top Of Its Debt

Simply Wall StAug 20, 2024 03:36 ET

Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Shares May Have Run Too Fast Too Soon

Simply Wall StJul 24, 2024 21:21 ET

Individual Investors Are Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Biggest Owners and Were Hit After Market Cap Dropped CN¥516m

Simply Wall StJun 6, 2024 18:05 ET